Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma

The definition of asthma has changed considerably in recent years, to the extent that asthma is no longer considered a single disease but a heterogeneous disorder that includes several phenotypes and, possibly, endotypes. A more detailed analysis of the immunological mechanisms underlying the pathog...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, Francesca Puggioni, Giovanni Passalacqua, Giorgio Walter Canonica
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2017-08-01
coleção:	Frontiers in Medicine
Assuntos:	interleukin 5 precision medicine personalized medicine severe asthma monoclonal antibodies biomarkers
Acesso em linha:	http://journal.frontiersin.org/article/10.3389/fmed.2017.00135/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!